Current
Neuro-Oncology

Volume 20 Number 5
31 May 2018

Home > Publications > Current Neuro-Oncology > Volume 20, Year 2018 > Number 5, 31 May

Johnstone JC.
A Case of Brain Tumour.
Edinb Med J. 1882 Dec;28(6):510-515→. PMID: 29647472→. Case report. ˍ

Davidoff LM, Ferraro A.
Intracranial Tumours among Mental Hospital Patients, with Special Attention to the Tumours of the Glioma Series.
Amer Journ Psychiatr. 1929;599-646.
Edinb Med J. 1930 Jan;37(1):55→. PMID: 29645619→. Observational study. ˍ

Joughin JL.
Coincident Brain Tumour in Twins.
Journ Nerv and Ment Dis. 1928;379-82.
Edinb Med J. 1930 Jun;37(6):370→. PMID: 29645606→. Case report. ˍ

Arora G, Sharma P, Sharma A, Mishra AK, Hazari PP, Biswas A, Garg A, Aheer D, Kumar R.
99mTc-Methionine Hybrid SPECT/CT for Detection of Recurrent Glioma: Comparison With 18F-FDG PET/CT and Contrast-Enhanced MRI.
Clin Nucl Med. 2018 May 1, 2018;43(5):e132-e138→. doi: 10.1097/RLU.0000000000002036→. PMID: 29517540→. Interventionalstudy. ˍ

Balaña C, Estival A, Teruel I, Hardy-Werbin M, Sepulveda J, Pineda E, Martinez-García M, Gallego O, Luque R, Gil-Gil M, Mesia C, Del Barco S, Herrero A, Berrocal A, Perez-Segura P, De Las Penas R, Marruecos J, Fuentes R, Reynes G, Velarde JM, Cardona A, Verger E, Panciroli C, Villà S.
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients.
Clin Transl Oncol. 2018 May 8, 2018;20(12):1529-1537→. doi: 10.1007/s12094-018-1883-7→. PMID: 29737461→. Observational study. ˍ

Tong L, Yi L, Liu P, Abeysekera IR, Hai L, Li T, Tao Z, Ma H, Xie Y, Huang Y, Yu S, Li J, Yuan F, Yang X.
Tumour cell dormancy as a contributor to the reduced survival of GBM patients who received standard therapy.
Oncol Rep. 2018 May 8, 2018;40(1):463-471→. doi: https://doi.org/10.3892/or.2018.6425→. PMID: 29749548→. Laboratory investigation. ˍ

Hoffman LM, Veldhuijzen van Zanten SEM, Colditz N, Baugh J, Chaney B, Hoffmann M, Lane A, Fuller C, Miles L, Hawkins C, Bartels U, Bouffet E, Goldman S, Leary S, Foreman NK, Packer R, Warren KE, Broniscer A, Kieran MW, Minturn J, Comito M, Broxson E, Shih CS, Khatua S, Chintagumpala M, Carret AS, Escorza NY, Hassall T, Ziegler DS, Gottardo N, Dholaria H, Doughman R, Benesch M, Drissi R, Nazarian J, Jabado N, Boddaert N, Varlet P, Giraud G, Castel D, Puget S, Jones C, Hulleman E, Modena P, Giagnacovo M, Antonelli M, Pietsch T, Gielen GH, Jones DTW, Sturm D, Pfister SM, Gerber NU, Grotzer MA, Pfaff E, von Bueren AO, Hargrave D, Solanki GA, Jadrijevic Cvrlje F, Kaspers GJL, Vandertop WP, Grill J, Bailey S, Biassoni V, Massimino M, Calmon R, Sanchez E, Bison B, Warmuth-Metz M, Leach J, Jones B, van Vuurden DG, Kramm CM, Fouladi M.
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries.
J Clin Oncol. 2018 May 10, 2018;36(19):1963-1972→. doi: 10.1200/JCO.2017.75.9308→. PMID: 29746225→. Observational study. ˍ

Kim SH, Yoo H, Chang JH, Kim CY, Chung DS, Kim SH, Park SH, Lee YS, Yang SH.
Procarbazine and CCNU Chemotherapy for Recurrent Glioblastoma with MGMT Promoter Methylation.
J Korean Med Sci. 2018 May 10, 2018;33(24):e167→. doi: 10.3346/jkms.2018.33.e167→. PMID: 29892208→. Interventional study. ˍ

Cloughesy TF, Landolfi J, Vogelbaum MA, Ostertag D, Elder JB, Bloomfield S, Carter B, Chen CC, Kalkanis SN, Kesari S, Lai A, Lee IY, Liau LM, Mikkelsen T, Nghiemphu P, Piccioni D, Accomando W, Diago OR, Hogan DJ, Gammon D, Kasahara N, Kheoh T, Jolly DJ, Gruber HE, Das A, Walbert T.
Durable Complete Responses in Some Recurrent High Grade Glioma Patients Treated with Toca 511 & Toca FC.
Neuro Oncol. 2018 May 12, 2018;20(10):1383-1392→. doi: 10.1093/neuonc/noy075→. PMID: 29762717→. Interventional study. ˍ

Otani R, Uzuka T, Higuchi F, Matsuda H, Nomura M, Tanaka S, Mukasa A, Ichimura K, Kim P, Ueki K.
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Cancer Sci. 2018 May 12, 2018;109(7):2327-2335→. doi: 10.1111/cas.13635→. PMID: 2975285→. Laboratory investigation. ˍ

Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E, Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques TS, Figarella-Branger D, Rodriguez D, Morgan PS, Raman P, Waanders AJ, Resnick AC, Massimino M, Garrè ML, Smith H, Capper D, Pfister SM, Würdinger T, Tam R, Garcia J, Thakur MD, Vassal G, Grill J, Jaspan T, Varlet P, Jones C.
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.
Cancer Cell. 2018 May 14, 2018;33(5):829-842.e5→. doi: 10.1016/j.ccell.2018.04.004→. PMID: 29763623→. Interventional study. ˍ

Geurts M, van den Bent MJ.
Timing of radiotherapy in newly diagnosed glioblastoma: no need to rush?
Neuro Oncol. 2018 May 15, 2018;20(7):868-869→. doi: 10.1093/neuonc/noy065→. PMID: 29767783→. Comment. ˍ
Refers to: Blumenthal DT et al., Short delay in initiation of radiotherapy for patients with glioblastoma- effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group (RTOG) database. Neuro Oncol. 2018 Feb 15, 2018;20(7):966-974→. doi: 10.1093/neuonc/noy017→. PMID: 29462493→. Meta-analysis. ˍ

Lassaletta A.
Medulloblastoma in infants: the never-ending challenge.
Lancet Oncol. 2018 May 16, 2018;19(6):720-721→. doi: 10.1016/S1470-2045(18)30278-X→. PMID: 29778736→. Comment. ˍ
Refers to: Robinson GW et al, Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol. 2018 May 16, 2018;19(6):768-784→. doi: 10.1016/S1470-2045(18)30204-3→. PMID: 29778738→. Interventional study. ˍ

Massimino M, Biassoni V, Miceli R, Schiavello E, Warmuth-Metz M, Modena P, Casanova M, Pecori E, Giangaspero F, Antonelli M, Buttarelli FR, Potepan P, Pollo B, Nunziata R, Spreafico F, Podda M, Anichini A, Clerici CA, Sardi I, De Cecco L, Bode U, Bach F, Gandola L.
Correction to: Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood.
J Neurooncol. 2018 May 16, 2018;138(3):679-680→. doi: 10.1007/s11060-018-2893-6→. PMID: 29767306→. Correction. ˍ
Refers to: Massimino M, et al, Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood. J Neurooncol. 2014 Apr 3, 2014;118(2):305-312→. doi: 10.1007/s11060-014-1428-z→. PMID: 24696052→. Expanded aceess study. ˍ

Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA.
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
Lancet Oncol. 2018 May 16, 2018;19(6):768-784→. doi: 10.1016/S1470-2045(18)30204-3→. PMID: 29778738→. Interventional study. ˍ

Pasqualetti F, Pace A, Gonnelli A, Villani V, Cantarella M, Delishaj D, Vivaldi C, Molinari A, Montrone S, Pellerino A, Franchino F, Baldaccini D, Lombardi G, Lolli I, Catania F, Bazzoli E, Morganti R, Fabi A, Zagonel V, Bocci G, Fabrini MG, Rudà R, Soffietti R, Paiar F.
Single-agent Bevacizumab in Recurrent Glioblastoma After Second-line Chemotherapy With Fotemustine: The Experience of the Italian Association of Neuro-Oncology.
Am J Clin Oncol. 2018 May 18. doi: 10.1097/COC.0000000000000464. Source . Similar articles

Mantica M, Pritchard A, Lieberman F, Drappatz J.
Retrospective study of nivolumab for patients with recurrent high grade gliomas.
J Neurooncol. 2018 May 19. doi: 10.1007/s11060-018-2907-4. Source . Similar articles

Mughal AA, Zhang L, Fayzullin A, Server A, Li Y, Wu Y, Glass R, Meling T, Langmoen IA, Leergaard TB, Vik-Mo EO.
Patterns of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as an Invasion-Spared Brain Region.
Neoplasia. 2018 May 21;20(7):643-656. doi: 10.1016/j.neo.2018.04.001. Source . Similar articles

Shah AS, Nicoletti LK, Kurtovic E, Tsien CI, Benzinger TLS, Chicoine MR.
Progression of Low-Grade Glioma During Pregnancy With Subsequent Regression Postpartum Without Treatment-A Case Report.
Neurosurgery. 2018 May 21. doi: 10.1093/neuros/nyy191. Source . Similar articles

von Bueren AO, Karremann M, Gielen GH, Benesch M, Fouladi M, van Vuurden DG, van Zanten SEMV, Hoffman LM, Kramm CM.
A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".
Acta Neuropathol. 2018 May 21, 2018;136(1):171-173. doi: 10.1007/s00401-018-1863-6. Source . Similar articles

Chen-Zhao X, Aznar-García L.
Diagnosis and management of spinal metastasis of primary brain tumours.
AME Case Rep. 2018 May 22;2:26. doi: 10.21037/acr.2018.03.02. Source . Similar articles

Mascaro-Cordeiro B, Oliveira ID, Tesser-Gamba F, Pavon LF, Saba-Silva N, Cavalheiro S, Dastoli P, Toledo SRC.
Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.
Childs Nerv Syst. 2018 May 22. doi: 10.1007/s00381-018-3817-7. Source . Similar articles

Sanai N, Li J, Boerner J, Stark K, Wu J, Kim S, Derogatis A, Mehta S, Dhruv HD, Heilbrun LK, Berens ME, LoRusso PM.
Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients.
Clin Cancer Res. 2018 May 24. doi: 10.1158/1078-0432.CCR-17-3348. Source . Similar articles

Dasgupta A, Gupta T, Pungavkar S, Shirsat N, Epari S, Chinnaswamy G, Mahajan A, Janu A, Moiyadi A, Kannan S, Krishnatry R, Goda JS, Jalali R.
Nomograms based on Pre-operative Multi-parametric Magnetic Resonance Imaging for Prediction of Molecular Subgrouping in Medulloblastoma: Results from a Radiogenomics Study of 111 Patients.
Neuro Oncol. 2018 May 29. doi: 10.1093/neuonc/noy093. Source . Similar articles

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walpert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Source . Similar articles